IkT-148009 - Addressing Loss of Function in Parkinson's Patients Inhibikase Therapeutics 1:19 1 year ago 3 083 Далее Скачать
IkT-148009 as a potential disease-modifying therapy in Parkinson's disease VJNeurology 3:56 2 years ago 1 594 Далее Скачать
Parkinson's disease modification through c-Abl inhibition VJNeurology 4:55 2 years ago 1 282 Далее Скачать
Inhibikase Therapeutics: Developing Therapies to Reverse Parkinson’s Disease Inhibikase Therapeutics 49:21 2 years ago 7 605 Далее Скачать
Disease Modification of Parkinson's Disease Through Oral Kinase Inhibitor Therapy Inhibikase Therapeutics 18:37 3 years ago 2 496 Далее Скачать
Inhibikase Therapeutics Talks Focus on Developing Therapeutics for Parkinson's and Related Disorders Planet MicroCap 9:49 1 year ago 436 Далее Скачать
IKT President & CEO Provides a Brief Overview of the Company Inhibikase Therapeutics 1:36 1 year ago 436 Далее Скачать
Enrolling treatment-naive patients in Parkinson’s disease clinical trials VJNeurology 2:22 1 year ago 620 Далее Скачать
Inhibikase Virtual KOL Event: Developing Novel Therapeutics for Parkinson’s Disease Inhibikase Therapeutics 1:30:08 2 years ago 4 413 Далее Скачать
Inhibikase: Innovating Kinase Inhibitor Therapeutics for Neurodegenerative Diseases Inhibikase Therapeutics 20:02 3 years ago 593 Далее Скачать
Addressing Patient Hesitancy in Parkinson Treatment With Education NeurologyLive 4:09 1 year ago 47 Далее Скачать
Risvodetinib Designated as an Orphan Drug by U.S. FDA. Inhibikase Therapeutics 2:15 1 year ago 706 Далее Скачать
Inhibikase Therapeutics making 'substantial progress' on Phase 1 trial to treat Parkinson's disease Proactive Investors 5:23 3 years ago 1 614 Далее Скачать
TRAP: Symptoms of Parkinson Disease | Medical Mnemonic | Merck Manual Professional Version Merck Manuals 0:18 1 year ago 56 960 Далее Скачать
